Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Madrigal Pharmaceuticals Inc (MDGL)  
$210.98 0.34 (0.16%) as of 4:30 Tue 5/14


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 19,740,000
Market Cap: 4.16(B)
Last Volume: 9,322,967 Avg Vol: 9,297,189
52 Week Range: $120.4 - $292.92
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 25.1
Insider 3/6 Months : 25.7
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Co.'s primary product candidate, resmetirom, is being developed as a once-daily oral pill to treat several disease states, including non-alcoholic steatohepatitis, or NASH. Co. has initiated MAESTRO-NASH, a Phase 3 trial in NASH with its once daily, oral thyroid hormone receptor beta selective agonist, resmetirom. Co. has opened for enrollment MAESTRO-NAFLD-1, a Phase 3 clinical study of patients with biopsy-confirmed or presumed NASH recruited from sites in the U.S.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 282,998 424,685 424,685
Total Buy Value $0 $56,602,533 $77,751,391 $77,751,391
Total People Bought 0 1 1 1
Total Buy Transactions 0 7 10 10
Total Shares Sold 252,542 270,142 270,142 339,631
Total Sell Value $62,399,106 $66,219,580 $66,219,580 $85,688,008
Total People Sold 5 7 7 8
Total Sell Transactions 13 21 21 26
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 187
  Page 8 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Schor Chen President and CEO   •       •      –    2015-06-05 4 A $0.00 $0 D/D 150,000 300,000     -
   Kovner Bruce Director   –       •       •   2015-04-06 4 B $1.75 $12,000,000 I/I 6,857,143 15,278,610 2.25     -
   Gollust Keith R Director   –       •      –    2015-04-06 4 B $1.75 $612,500 I/I 350,000 3,173,383 2.1     -
   Wilson Robert N Director   –       •      –    2015-04-06 4 B $1.75 $87,500 D/D 50,000 754,118 2.39     -
   Schor Chen Executive VP and COO   •       –      –    2014-12-08 4 A $0.00 $0 D/D 150,000 150,000     -
   Schneebaum Marc R SVP and CFO   •       –      –    2014-12-08 4 A $0.00 $0 D/D 75,000 75,000     -
   Kovner Bruce Director   –       •       •   2014-09-30 4 B $3.08 $923,130 I/I 300,000 8,421,467 2.25     -
   Whitaker Anne Clem President and CEO   •       •      –    2014-09-02 4 A $0.00 $0 D/D 500,000 500,000     -
   Gollust Keith R Director   –       •      –    2014-07-01 4 A $0.00 $0 D/D 19,511 351,766     -
   Kovner Bruce Director   –       •       •   2014-07-01 4 A $0.00 $0 D/D 12,194 3,060,860     -
   Reardon William S Director   –       •      –    2014-07-01 4 A $0.00 $0 D/D 4,878 41,439     -
   Wilson Robert N Director   –       •      –    2014-07-01 4 A $0.00 $0 D/D 2,439 704,118     -
  187 Records found
  1  2  3  4  5  6  7  8    
  Page 8 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us